Skaana Management L.P. Novavax Inc Put Options Transaction History

Skaana Management L.P.

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$10.71 - $17.11 $2.01 Million - $3.21 Million	187,700 Added 199.89%	281,600 $3.56 Million
Q2 2024 Jul 31, 2024	BUY	$3.89 - $20.97 $252,461 - $1.36 Million	64,900 Added 223.79%	93,900 $1.19 Million
Q1 2024 May 14, 2024	SELL	$3.76 - $6.02 $1.11 Million - $1.78 Million	-296,000 Reduced 91.08%	29,000 $138,000
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $1.34 Million - $2.13 Million	278,200 Added 594.44%	325,000 $1.56 Million
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $209,067 - $299,018	-30,700 Reduced 39.61%	46,800 $338,000
Q2 2023 Aug 14, 2023	SELL	$6.67 - $9.52 $2.91 Million - $4.16 Million	-436,500 Reduced 84.92%	77,500 $575,000
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $1.75 Million - $3.79 Million	303,900 Added 144.65%	514,000 $3.56 Million
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $1.86 Million - $5.26 Million	210,100 New	210,100 $2.16 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Skaana Management L.P., based on Form 13F filings with the SEC.

Stay updated on Skaana Management L.P. with notifications on news.